Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT
Supported in part by an unrestricted Departmental Challenge Grant from Research to Prevent Blindness, Inc., New York, NY.
Disclosure: Dr M. Bruce Shields serves as a consultant for Opko Health. No other authors have any financial/conflicting interests to disclose for this study.
Contributions of authors: design of the study (J.C.T., N.A.L., N.N.); data collection (N.N., J.C.T., M.B.S.), conduct of the study (N.N., N.A.L.); manuscript writing and revision (N.N., J.C.T., M.B.S., N.A.L.). This study adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of Yale University, also known as the Human Investigations Committee.
Reprints: Nils A. Loewen, MD, PhD, Department of Ophthalmology and Visual Science, Yale University School of Medicine, 40 Temple Street, Suite 3D, Room 375, New Haven, CT 06510-2715 (e-mail: [email protected]).
Received September 28, 2010
Accepted April 18, 2011